KRAS and neoplasm: Also, individualizing organoid culture media to target driver mutations in the patient tumor genetic profile, such as EGF-depleted media to enrich for KRAS mutants, may increase PDO formation and eliminate nontumor “contaminants” that may inhibit PDO growth (44).